Literature DB >> 8587801

Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.

P G Fallon1, R E Fookes, G A Wharton.   

Abstract

A temporal study of the effects on the tegument of Schistosoma mansoni adult worm following in vivo praziquantel and oxamniquine treatment was performed. Drug-induced damage to the tegument, exposure of surface antigens and attachment of host antibody occurred rapidly, within 1 h, following praziquantel treatment. Oxamniquine-treated worms required 4-8 days for these effects to be apparent. The 2 drugs differed in the degree and sites of damage on the worm surface. The administration of 2 different polyspecific rabbit sera with drug significantly increased the efficacy of praziquantel when administered with the drug, but not when given 6-9 days after drug treatment. In contrast, only 1 serum was synergistic with oxamniquine when administered with drug and both sera were synergistic when given 6-9 days after drug treatment. The effect of immune killing of drug-treated worms is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8587801     DOI: 10.1017/s0031182000065069

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  11 in total

1.  Schistosomiasis: progress and problems.

Authors:  George Y Wu; Mohab H Halim
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Schistosoma mansoni Worm Infection Regulates the Intestinal Microbiota and Susceptibility to Colitis.

Authors:  Achilleas Floudas; Gabriella Aviello; Christian Schwartz; Ian B Jeffery; Paul W O'Toole; Padraic G Fallon
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms.

Authors:  Humberto Gonçalves Bertão; Renata Alexandre Ramos da Silva; Rafael José R Padilha; Mônica Camelo Pessôa de Azevedo Albuquerque; Gandhi Rádis-Baptista
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

4.  Preliminary characterization of an adult worm "vomit" preparation of Schistosoma mansoni and its potential use as antigen for diagnosis.

Authors:  Sandra Planchart; Renzo Nino Incani; Italo Mario Cesari
Journal:  Parasitol Res       Date:  2007-02-20       Impact factor: 2.289

5.  Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.

Authors:  Serry A El Bialy; Amira Taman; Samar N El-Beshbishi; Basem Mansour; Mohamed El-Malky; Waleed A Bayoumi; Hassan M Essa
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

Review 6.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

7.  The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses.

Authors:  Colin M Fitzsimmons; Frances M Jones; Alex Stearn; Iain W Chalmers; Karl F Hoffmann; Jakub Wawrzyniak; Shona Wilson; Narcis B Kabatereine; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2012-04-03

8.  Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection.

Authors:  Nadine Rujeni; Norman Nausch; Nicholas Midzi; Graeme J Cowan; Richard Burchmore; David R Cavanagh; David W Taylor; Takafira Mduluza; Francisca Mutapi
Journal:  J Trop Med       Date:  2013-06-05

9.  Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.

Authors:  Mohamed Z Satti; Pierre Cahen; Per S Skov; Sarah Joseph; Frances M Jones; Colin Fitzsimmons; Karl F Hoffmann; Claus Reimert; H Curtis Kariuki; Francis Kazibwe; Joseph K Mwatha; Gachuhi Kimani; Birgitte J Vennervald; John H Ouma; Narcis B Kabatereine; David W Dunne
Journal:  BMC Immunol       Date:  2004-04-21       Impact factor: 3.615

10.  Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.

Authors:  Gordana Panic; Marie-Thérèse Ruf; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.